HSCS
HSCS
NASDAQ · Health Care

Heartsciences Inc

$4.43
-0.30 (-6.34%)
As of Sep 28, 10:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
7.7K
Net Income
-16,860,340
Gross Margin
59.0%
Profit Margin
-211,617.6%
Rev Growth
-6.0%
D/E Ratio
16.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 46.4% 46.4%
Operating Margin -194,742.4% -175,281.1% 16.1% 16.8%
Profit Margin -211,617.6% -201,036.7% 17.0% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 7.7K 8.2K 3.30M 3.40M
Gross Profit 4.6K 4.9K 1.53M 1.58M
Operating Income -15,086,690 -14,443,166 530.1K 570.8K
Net Income -16,860,340 -16,141,161 560.2K 453.4K
Gross Margin 59.0% 59.0% 46.4% 46.4%
Operating Margin -194,742.4% -175,281.1% 16.1% 16.8%
Profit Margin -211,617.6% -201,036.7% 17.0% 13.3%
Rev Growth -6.0% -6.0% +13.2% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.46M 10.46M 3.60M 4.54M
Total Equity 652.8K 652.8K 4.32M 3.69M
D/E Ratio 16.02 16.02 0.83 1.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -15,464,390 -15,627,242 944.9K 908.1K
Free Cash Flow — — 381.1K 454.7K